Vivo PANDA is a new, life science-focused venture fund

Vivo CapitalVivo PANDA is a new, $100 million plus venture fund created to invest primarily in innovative early stage healthcare companies across a broad spectrum, but with a particular focus on pharmaceuticals, biotechnology, medical devices, and diagnostics. Read more about the new fund here.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.